Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 16 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 16 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 16 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More

Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, June 16 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More

The road to "Insurance for All" runs through claims and servicing: Policybazaar's vision

India, June 16 -- justify;">Gurugram: Insurance is a promise. But that promise is tested only when a customer needs help. A policy purchase is just the beginning. The real moment of truth comes at the... Read More

England's Robinson ruled out of second Test against New ZealandPublished on: June 16, 2026 10:03 AM

Pakistan, June 16 -- Seamer Ollie Robinson, whose player-of-the-match performance guided England to victory in the first Test against New Zealand, will miss the second match due to a sore right knee, ... Read More

NTA welcomes temporary Telegram restrictions ahead of NEET-UG re-exam

India, June 16 -- The National Testing Agency (NTA) on Tuesday welcomed the Centre's decision to impose temporary restrictions on the Telegram platform in India ahead of the NEET-UG 2026 re-examinatio... Read More

Baba Ijesha and his fashion stylist wife welcome a baby boy

Nigeria, June 16 -- Yoruba actor Olanrewaju "Baba Ijesha" James and his wife, fashion stylist Abiodun Tokunbo, have welcomed a newborn baby boy. Baba Ijesha announced the new arrival on his Facebook ... Read More

AISHE registration made mandatory: Haryana asks all unregistered institutions to complete process urgently

Panchkula, June 16 -- Seeking to ensure accurate data collection on student enrolment, faculty strength, infrastructure and academic programmes across educational institutions, the Haryana Higher Educ... Read More

Telangana: ACB conducts searches at residence of Lands and Survey Dy Director

Hyderabad, June 16 -- The Anti-Corruption Bureau (ACB) on Tuesday conducted searches at the residence of Lands and Survey Deputy Director Sunkari Narahari from early morning. Published by HT Digital ... Read More

• ««
• «
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• »
• »»